Mark R. Wilkinson
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Adverse Reactions
-
- Pharmaceutical studies and practices
Papers in
-
- Epigenetics and DNA Methylation 3
-
- Acute Lymphoblastic Leukemia research 4
- Co-authors
- James M. Hoffman (4 shared papers)Mary V. Relling (7 shared papers)William E. Evans (6 shared papers)Wenjian Yang (5 shared papers)Nancy M. Kornegay (3 shared papers)Cyrine E. Haidar (3 shared papers)Donald K. Baker (3 shared papers)Kristine R. Crews (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Journal of the American Medical Informatics Association (1 paper)Genes Chromosomes and Cancer (1 paper)IEEE Transactions on Power Delivery (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Mark R. Wilkinson
17 papers receiving 748 citations
Peers
Comparison fields: 5 of 90
- Pharmacology 369
- Pediatrics, Perinatology and Child Health 202
- Geriatrics and Gerontology 28
- Statistics and Probability 55
- Genetics 137
Countries citing papers authored by Mark R. Wilkinson
This map shows the geographic impact of Mark R. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Wilkinson more than expected).
Fields of papers citing papers by Mark R. Wilkinson
This network shows the impact of papers produced by Mark R. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Wilkinson. The network helps show where Mark R. Wilkinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark R. Wilkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 206 | |
| 2 | 2013 | 159 | |
| 3 | 2014 | 106 | |
| 4 | 2012 | 77 | |
| 5 | 2016 | 62 | |
| 6 | 2003 | 44 | |
| 7 | 2004 | 23 | |
| 8 | 2022 | 20 | |
| 9 | 2002 | 19 | |
| 10 | 2014 | 18 | |
| 11 | 2005 | 13 | |
| 12 | 2021 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2020 | 4 | |
| 15 | 2002 | 2 | |
| 16 | 2022 | 2 | |
| 17 | Exploring Cosmic Ray Sensor data to evaluate large scale water storage dynamics in humid mixed landscapes | 2018 | 1 |
About Mark R. Wilkinson
Mark R. Wilkinson is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Pharmacology, Mechanical Engineering and Genetics, having authored 17 papers that have together received 767 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Heat Transfer Mechanisms (3 papers), Epigenetics and DNA Methylation (3 papers), Radiative Heat Transfer Studies (2 papers), Power Transformer Diagnostics and Insulation (2 papers), Glioma Diagnosis and Treatment (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Pharmacology (369 citations), Pediatrics, Perinatology and Child Health (202 citations), Geriatrics and Gerontology (28 citations), Statistics and Probability (55 citations) and Genetics (137 citations). Mark R. Wilkinson has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include James M. Hoffman, Mary V. Relling, William E. Evans, Wenjian Yang, Nancy M. Kornegay, Cyrine E. Haidar, Donald K. Baker, Kristine R. Crews, Ulrich Broeckel and Scott C. Howard. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Clinical Pharmacology & Therapeutics, Journal of the American Medical Informatics Association, Genes Chromosomes and Cancer and IEEE Transactions on Power Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.